Actoverco group’s public relations issued a statement, strongly denying the rumors about the export of Sputnik vaccine to Russia. In this regard, we announce that Actoverco has started the industrial production of Sputnik Light vaccine and has received all the necessary approvals from the Gamaleya Institute of Russia and is waiting for the approval of country’s Food and Drug Administration. In order to produce vaccines of other Iranian companies and build capacity for these corporations, Actoverco, by considering this as its national duty, also declares the necessary readiness to evacuate its drug production lines to help produce vaccines and employ its capital and knowledge in vaccinating the people of the country. Additionally it will not allow even one vial of Sputnik vaccine to leave the Actoverco corporation abroad until the termination of Iranian people vaccination. Also, due to the repeated denial of these rumors by all relevant authorities in Iran and Russia, the legal department of this company reserves the right to prosecute these persons.